Inhibition of Monocarboxylate transporter 1 (MCT1), direct targeting of lactate metabolism, or inhibition of tumor acidity may break the metabolic symbiosis between tumor cells and Treg cells, thus reducing the Treg barrier of tumor immunity and enhancing the killing function of effector T cells (61). The gene discussed is SLC16A1; the disease is neoplasm.